Unknown

Dataset Information

0

COVID-19 and Interstitial Lung Disease: Keep Them Separate.

ABSTRACT:

SUBMITTER: Podolanczuk AJ 

PROVIDER: S-EPMC7737597 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

COVID-19 and Interstitial Lung Disease: Keep Them Separate.

Podolanczuk Anna J AJ   Richeldi Luca L  

American journal of respiratory and critical care medicine 20201201 12

Similar Datasets

Unknown How COVID-19 interacts with interstitial lung disease.
| S-EPMC8908865 | biostudies-literature
Unknown Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID).
| S-EPMC8461362 | biostudies-literature
Unknown Tacrolimus Treatment for Post-COVID-19 Interstitial Lung Disease.
| S-EPMC8907778 | biostudies-literature
Unknown Lungs after COVID-19: Evolving Knowledge of Post-COVID-19 Interstitial Lung Disease.
| S-EPMC8086543 | biostudies-literature
Unknown Pulmonary Sequelae of COVID-19: Focus on Interstitial Lung Disease.
| S-EPMC10527752 | biostudies-literature
Unknown A case of severe interstitial lung disease after COVID-19 vaccination.
| S-EPMC8522437 | biostudies-literature
Unknown Interstitial lung disease before and after COVID-19: a double threat?
| S-EPMC8637181 | biostudies-literature
Unknown Interstitial lung disease after receiving the mRNA-based COVID-19 vaccine tozinameran.
| S-EPMC8858430 | biostudies-literature
Unknown Lung cancer surgery during COVID-19: keep calm and operate on.
| S-EPMC9840032 | biostudies-literature
Unknown Persistent Post-COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment.
| S-EPMC8086530 | biostudies-literature